Covid-19: EU sues AstraZeneca over 'delayed deliveries' of vaccine

0:00
play article
Subscribers can listen to this article
The European Commission has launched court proceedings against AstraZeneca.
The European Commission has launched court proceedings against AstraZeneca.
John Beckmann/BSR Agency/Getty Images
  • The European Commission has launched legal action against Covid-19 vaccine manufacturer AstraZeneca.
  • The commission alleges that the company has not respected a contract to supply vaccines.
  • AstraZeneca, however, has described the action as having "no merit".


The European Commission said on Monday it had launched legal action against AstraZeneca for not respecting its contract for the supply of Covid-19 vaccines and for not having a "reliable" plan to ensure timely deliveries.

AstraZeneca said in response that the legal action by the EU was without merit and pledged to defend itself strongly in court.

"AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will strongly defend itself in court. We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible," AstraZeneca said in a statement on Monday.

READ | Is the AstraZeneca vaccine safe? WHO is positive, but EU still deciding

Under the contract, the Anglo-Swedish company had committed to making its "best reasonable efforts" to deliver 180 million vaccine doses to the EU in the second quarter of this year, for a total of 300 million in the period from December to June.

But AstraZeneca said in a statement on 12 March it would aim to deliver only one-third of that by the end of June, of which about 70 million in the second quarter. A week after that, the Commission sent a legal letter to the company in the first step of a formal procedure to resolve disputes.

"The Commission has started last Friday a legal action against AstraZeneca," the EU spokesperson told a news conference, noting all 27 EU states backed the move.

Triggered

"Some terms of the contract have not been respected and the company has not been in a position to come up with a reliable strategy to ensure timely delivery of doses," the spokesperson said, explaining what triggered the move.

Under the contract, the case will need to be resolved by Belgian courts.

"We want to make sure there is a speedy delivery of a sufficient number of doses that European citizens are entitled to and which have been promised on the basis of the contract," the spokesman said.

"Every vaccine dose counts," EU health commissioner Stella Kyriakides said on Twitter, announcing the legal proceedings against AstraZeneca.

Germany, France and Hungary were among EU states that were initially reticent to sue the company, diplomats said, but eventually they supported the move.

The EU wants AstraZeneca to deliver the promised 300 million doses, but in a further sign of its irritation towards the company, it has already forgone another 100 million shots that it had an option to buy under the contract signed in August.

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For only R75 per month, you have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today.
Subscribe to News24
Lockdown For
DAYS
HRS
MINS
Voting Booth
Is social media doing more harm than good?
Please select an option Oops! Something went wrong, please try again later.
Results
Yes, our children are exposed and we can't protect them
49% - 4088 votes
Yes, but social media is part of the new reality
46% - 3778 votes
No, it's great for growing a child's world view
5% - 404 votes
Vote
USD/ZAR
14.09
-0.8%
GBP/ZAR
19.70
-0.2%
EUR/ZAR
17.12
-0.2%
AUD/ZAR
11.05
-0.1%
JPY/ZAR
0.13
-0.5%
Gold
1,832.66
+1.0%
Silver
27.39
+0.3%
Palladium
2,926.54
-0.8%
Platinum
1,254.00
-0.1%
Brent Crude
68.09
-1.3%
Top 40
62,573
+1.4%
All Share
68,520
+1.4%
Resource 10
71,474
+2.1%
Industrial 25
86,856
+0.9%
Financial 15
12,711
+1.1%
All JSE data delayed by at least 15 minutes Iress logo